ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

NCT00231946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

555

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: VP4896

Sponsor

Voyager Pharmaceutical Corporation